Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Citius Pharmaceuticals, Inc.

TRADE

NASDAQ: CTXR / / -
1.42+0.09+6.77%Vol 163 7191Y Perf -49.47%
Aug 15th, 2018 12:01
BID1.37 ASK1.43
Open1.50 Previous Close1.33
Pre-Market- After-Trading-
 - -%  - -%
Target Price
10.50 
Analyst Rating
Strong Buy 1.00
Potencial %
634.27 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)15 
Earnings Rating
Price Range Ratio 52wk %
6.86 
Earnings Date

Today's Price Range

1.361.55

 

52wk Range

1.125.49

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
-56.96%
3 Months
-43.88%
6 Months
-61.78%
1 Year
-49.47%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CTXR1.420.09006.77
AAPL208.57-1.1800-0.56
GOOG1 213.82-28.2800-2.28
MSFT107.29-2.2700-2.07
XOM76.98-1.3300-1.70
WFC58.02-0.0500-0.09
JNJ129.650.15000.12
FB176.38-4.7300-2.61
GE12.19-0.1600-1.30
JPM113.57-1.0800-0.94
...

TickerPriceChg.%52 Week High
CMG520.965.60521.40
KMB115.614.03124.15
BSX34.632.7637.30
PCG43.752.1271.57
CLX144.792.08150.40
PGR63.531.9964.77
HCP26.791.9430.59
EIX68.221.8583.38
HSY100.401.82115.82
ARE126.741.80134.37
ED79.921.7889.70
LUV60.141.7866.99
VTR58.361.5569.92
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.00
Current Ratio 2.00
Long Term Debt to Total Capital -
Total Debt to Equity 0.01
Interest Coverage -14.90
Leverage Ratio 1.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 0.64
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -1.50
Cash Flow Per Share -1.62
Price to Tangible Book5.94
Book Value per Share2.20
Enterprise Value (in ths.)10 113
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-87.41
ROE last 12 Months -70.06
Return on Assets (5Y Avg) -19.42
ROA last 12 Months -55.42
Return on Capital (5Y Avg) -
ROC last 12 Months -62.02
Return on invested Capital Q -17.77
Return on invested Capital Y-48.20
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.3274.40Positive
9/2018 FY-1.26--
9/2019 FY-0.54--
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume163 719
Shares Outstanding (in ths.)10 680
Trades Count396
Dollar Volume232 029
Avg. Volume80 239
Avg. Weekly Volume1 058 037
Avg. Monthly Volume341 979
Avg. Quarterly Volume143 751

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

75%25%

Bearish Bullish

43%57%

Bearish Bullish

53%47%

Bearish Bullish

48%52%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x